Relatively High Free Cash Flow Per Share Detected in Shares of Biogen Idec in the Biotechnology Industry (BIIB, AMGN, GILD, UTHR, REGN)
Below are the three companies in the Biotechnology industry with the highest free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.
Biogen Idec ranks highest with a FCF per share of $11.23. Amgen is next with a FCF per share of $10.33. Gilead Sciences ranks third highest with a FCF per share of $8.06.
United Therapeutics follows with a FCF per share of $6.39, and Regeneron Pharmaceuticals rounds out the top five with a FCF per share of $4.08.
SmarTrend recommended that subscribers consider buying shares of Biogen Idec on July 7th, 2016 as our technology indicated a new Uptrend was in progress when shares hit $247.44. Since that recommendation, shares of Biogen Idec have risen 29.9%. We continue to monitor Biogen Idec for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: highest free cash flow per share Biogen Idec Amgen Gilead Sciences United Therapeutics regeneron pharmaceuticals